33 Subsidiaries
|
|
Subsidiary |
|
Equity participation |
|
Registered capital (including paid-in capital in the USA) |
|
Direct participation by medmix Ltd |
|
Research and development |
|
Production and engineering |
|
Sales |
|
Service |
Europe |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Switzerland |
|
Sulzer Mixpac AG, Haag |
|
100% |
|
CHF 100’000 |
|
|
|
• |
|
• |
|
• |
|
|
|
|
Applicator Systems AG, Zug 1) |
|
100% |
|
CHF 100’000 |
|
• |
|
|
|
|
|
|
|
|
Czech Republic |
|
Haselmeier s.r.o., Dnesice |
|
100% |
|
CZK 50’200’000 |
|
|
|
|
|
• |
|
|
|
|
Germany |
|
Sulzer APS Deutschland Holding GmbH, Bechhofen |
|
100% |
|
EUR 870’000 |
|
|
|
|
|
|
|
|
|
|
|
|
Geka GmbH, Bechhofen |
|
100% |
|
EUR 878’600 |
|
|
|
• |
|
• |
|
• |
|
• |
|
|
Sulzer Mixpac Deutschland GmbH, Kiel |
|
100% |
|
EUR 26’000 |
|
|
|
• |
|
• |
|
• |
|
• |
|
|
Haselmeier GmbH, Stuttgart |
|
100% |
|
EUR 2’027’700 |
|
|
|
• |
|
|
|
• |
|
• |
UK |
|
Sulzer Mixpac (UK) Ltd., Hungerford |
|
100% |
|
GBP 1’000’000 |
|
|
|
|
|
• |
|
• |
|
|
Poland |
|
Sulzer Mixpac Poland Sp. z o.o., Nowa Wies Wroclawska |
|
100% |
|
PLN 5’000 |
|
|
|
|
|
• |
|
|
|
|
North America |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
USA |
|
Sulzer Mixpac USA Inc., Salem, New Hampshire |
|
100% |
|
USD 100 |
|
|
|
|
|
|
|
• |
|
|
|
|
Geka Manufacturing Corporation, Elgin, Illinois |
|
100% |
|
USD 603’719 |
|
|
|
|
|
• |
|
• |
|
• |
|
|
Sulzer APS US Holding Inc., Salem, New Hampshire 1) |
|
100% |
|
USD 1’000 |
|
|
|
|
|
|
|
|
|
|
|
|
Haselmeier Inc., Lowell, Massachusetts |
|
100% |
|
USD 1 |
|
|
|
|
|
|
|
• |
|
|
Central and South America |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil |
|
Geka do Brasil Indústria e Comércio de Embalagens Ltda., Cotia |
|
100% |
|
BRL 15’009’794 |
|
|
|
|
|
• |
|
• |
|
• |
Asia |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
India |
|
Haselmeier India Pvt. Ltd., Bengaluru |
|
100% |
|
INR 32’309’720 |
|
|
|
|
|
• |
|
|
|
|
People’s Republic of China |
|
Sulzer Applicators System Shanghai Ltd., Shanghai 1) |
|
100% |
|
CHF 1’000’000 |
|
|
|
|
|
• |
|
|
|
|
1) Established in 2021.